These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33292437)

  • 1. A single centre retrospective study of systemic reactions to subcutaneous immunotherapy.
    Robertson K; Montazeri N; Shelke U; Jeimy S; Kim H
    Allergy Asthma Clin Immunol; 2020 Nov; 16(1):93. PubMed ID: 33292437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing the risk of anaphylaxis requiring epinephrine in oral immunotherapy and subcutaneous immunotherapy: A review of recent Canadian real-world literature.
    Kovaltchouk U; Jeimy S; Soller L; Robertson K; Abrams EM; Cameron SB; Kim H; Chan ES
    J Allergy Clin Immunol Glob; 2023 May; 2(2):100080. PubMed ID: 37780796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AAAAI/ACAAI Subcutaneous Immunotherapy Surveillance Study (2013-2017): Fatalities, Infections, Delayed Reactions, and Use of Epinephrine Autoinjectors.
    Epstein TG; Liss GM; Berendts KM; Bernstein DI
    J Allergy Clin Immunol Pract; 2019; 7(6):1996-2003.e1. PubMed ID: 30776526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic reactions to subcutaneous allergen immunotherapy: real-world cause and effect modelling.
    Aue A; Ho J; Zhu R; Kim H; Jeimy S
    Allergy Asthma Clin Immunol; 2021 Jul; 17(1):65. PubMed ID: 34229743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic reactions to subcutaneous immunotherapy: Effects of dosing and aeroallergen content.
    Mustafa SS; Bingemann T; Blue H; Conn K; Hanley T; Ramsey A
    Ann Allergy Asthma Immunol; 2019 Sep; 123(3):284-287. PubMed ID: 31276805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk factors of systemic allergic reactions caused by subcutaneous allergen immunotherapy].
    Li LS; Guan K; Yin J; Wang LL; Zhi YX; Sun JL; Li H; Wen LP; Tang R; Gu JQ; Wang ZX; Cui L; Xu YY; Bian SN
    Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Dec; 57(12):1972-1977. PubMed ID: 38186144
    [No Abstract]   [Full Text] [Related]  

  • 7. Administration and Burden of Subcutaneous Immunotherapy for Allergic Rhinitis in U.S. and Canadian Clinical Practice.
    Blume SW; Yeomans K; Allen-Ramey F; Smith N; Kim H; Lockey RF; Nichol MB
    J Manag Care Spec Pharm; 2015 Nov; 21(11):982-90. PubMed ID: 26521110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective evaluation of adverse reactions after subcutaneous allergen-specific immunotherapy in children with house dust mite allergy.
    Altas U; Cetemen A; Altas ZM; Akkelle E; Ozkars MY
    North Clin Istanb; 2023; 10(5):675-680. PubMed ID: 37829749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic Reactions in Pediatric Patients Receiving Standardized Allergen Subcutaneous Immunotherapy with and without Seasonal Dose Adjustment.
    Albuhairi S; Sare T; Lakin P; El Khoury K; Crestani E; Schneider LC; Anzaldi R; Patterson A; Rachid R
    J Allergy Clin Immunol Pract; 2018; 6(5):1711-1716.e4. PubMed ID: 29339129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AAAAI/ACAAI surveillance study of subcutaneous immunotherapy, years 2008-2012: an update on fatal and nonfatal systemic allergic reactions.
    Epstein TG; Liss GM; Murphy-Berendts K; Bernstein DI
    J Allergy Clin Immunol Pract; 2014; 2(2):161-7. PubMed ID: 24607043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic reactions to subcutaneous allergen immunotherapy and the response to epinephrine.
    Phillips JF; Lockey RF; Fox RW; Ledford DK; Glaum MC
    Allergy Asthma Proc; 2011; 32(4):288-94. PubMed ID: 21781404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of adverse reactions induced by subcutaneous immunotherapy against dust mite allergy in 234 cases with allergic rhinitis and asthma].
    Li MR; Wang XN; Jiang HD; Wang QY; Li YC; Lin J; Jin K; Zhang HL; Li CC
    Zhonghua Er Ke Za Zhi; 2012 Oct; 50(10):726-31. PubMed ID: 23302557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk factors and management of systemic reactions induced by subcutaneous immunotherapy].
    Wen L; Wen Z; Yang N
    Zhonghua Yi Xue Za Zhi; 2014 Oct; 94(38):3001-4. PubMed ID: 25547703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of systemic allergic reactions to allergen immunotherapy in a pediatric allergy clinic in Turkey.
    Bahceci Erdem S; Nacaroglu HT; Karaman S; Unsal Karkıner CS; Gunay I; Dogan D; Asilsoy S; Altınoz S; Can D
    Int J Pediatr Otorhinolaryngol; 2016 May; 84():55-60. PubMed ID: 27063754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System.
    Cox L; Larenas-Linnemann D; Lockey RF; Passalacqua G
    J Allergy Clin Immunol; 2010 Mar; 125(3):569-74, 574.e1-574.e7. PubMed ID: 20144472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic reactions to subcutaneous allergen immunotherapy.
    Bernstein DI; Epstein T
    Immunol Allergy Clin North Am; 2011 May; 31(2):241-9, viii-ix. PubMed ID: 21530817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of subcutaneous immunotherapy with inhalant allergen extracts: a single-center 30-year experience from Turkey.
    Kartal O; Gulec M; Caliskaner Z; Musabak U; Sener O
    Immunopharmacol Immunotoxicol; 2015 Jun; 37(3):280-6. PubMed ID: 25858053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should Epinephrine Autoinjectors Be Prescribed to All Patients on Subcutaneous Immunotherapy?
    Fitzhugh DJ; Bernstein DI
    J Allergy Clin Immunol Pract; 2016; 4(5):862-7. PubMed ID: 27209596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diurnal variations in subcutaneous allergen immunotherapy reactions.
    Bavishi AA; Grammer LC; Pongracic J; Rychlik K; Kumar R; Zee P; Greenberger PA; Fishbein AB
    Ann Allergy Asthma Immunol; 2017 Jan; 118(1):103-107. PubMed ID: 27864091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of subcutaneous immunotherapy for allergic rhinoconjunctivitis and asthma: a systematic review.
    Erekosima N; Suarez-Cuervo C; Ramanathan M; Kim JM; Chelladurai Y; Segal JB; Lin SY
    Laryngoscope; 2014 Mar; 124(3):616-27. PubMed ID: 23832632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.